Home/Elthera/Jacques Gaudreault
JG

Jacques Gaudreault

COO & Board Member

Elthera

Therapeutic Areas

Elthera Pipeline

DrugIndicationPhase
Anti-L1CAM Antibody ProgramAggressive malignancies (unspecified cancer types)Pre-clinical